These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Atypical hypocomplementemic vasculitis syndrome in a child. Waldo FB; Leist PA; Strife CF; Forristal J; West CD J Pediatr; 1985 May; 106(5):745-50. PubMed ID: 2987470 [TBL] [Abstract][Full Text] [Related]
7. Disease states in genetic complement deficiencies. Tappeiner G Int J Dermatol; 1982 May; 21(4):175-91. PubMed ID: 6284665 [No Abstract] [Full Text] [Related]
8. Inherited deficiencies of complement in man. Ray TL; Wuepper KD Int J Dermatol; 1977 Dec; 16(10):775-92. PubMed ID: 340392 [No Abstract] [Full Text] [Related]
9. C3 metabolism in a patient with deficiency of the second component of complement (C2) and discoid lupus erythematosus. Wild JH; Zvaifler NJ; Müller-Eberhard HJ; Wilson CB Clin Exp Immunol; 1976 May; 24(2):238-48. PubMed ID: 1084239 [TBL] [Abstract][Full Text] [Related]
10. Developmental aspects of complement components in the newborn. The presence of complement components and C3 proactivator (properdin factor B) in human colostrum. Ballow M; Fang F; Good RA; Day NK Clin Exp Immunol; 1974 Oct; 18(2):257-66. PubMed ID: 4478765 [TBL] [Abstract][Full Text] [Related]
11. Lupus diseases associated with hereditary and acquired deficiencies of complement. Agnello V Springer Semin Immunopathol; 1986; 9(2-3):161-78. PubMed ID: 3544278 [No Abstract] [Full Text] [Related]
12. Relationship between the component and regulatory proteins of the classical pathway C3 convertase. Welch TR; Forristal J; Beischel L J Lab Clin Med; 1986 Jun; 107(6):529-33. PubMed ID: 3635565 [TBL] [Abstract][Full Text] [Related]
14. Complement deficiency states. Agnello V Medicine (Baltimore); 1978 Jan; 57(1):1-23. PubMed ID: 337041 [No Abstract] [Full Text] [Related]
15. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement. Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223 [TBL] [Abstract][Full Text] [Related]
16. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65. Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193 [TBL] [Abstract][Full Text] [Related]
17. [Complement deficiencies]. Meri S Duodecim; 1994; 110(2):185-94. PubMed ID: 7555791 [No Abstract] [Full Text] [Related]
19. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor. Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213 [TBL] [Abstract][Full Text] [Related]
20. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes. Brown EJ; Ramsey J; Hammer CH; Frank MM J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]